| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 03/08/2006 | CN1742731A Pyrazole-di-pyridineones for treating female sexual dysfunction |
| 03/08/2006 | CN1244584C Synthesis method of triethylene diamine from piperazine byproduct |
| 03/08/2006 | CN1244583C Tiemomium azoleamine-8-carboxylic acid ester and 8-amide derivatives, its synthesizing method and application in producing anticancer preparation |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/08/2006 | CN1244376C Releasable bond and composition containing said bond |
| 03/07/2006 | US7008957 6-amino-5-oxo--hexahydropyrrolo[2,1-b]thiazole-3-carbonitrile compounds of given formula; for the treatment of metabohlic disorders such as type 2 diabetes |
| 03/07/2006 | US7008948 Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors |
| 03/07/2006 | US7008947 Use to treat anxiety, depression, a sleep disorder such as primary insomnia, circadian rhythm sleep disorder, dyssomnia NOS, nightmare disorder, or attention deficit disorder |
| 03/07/2006 | US7008941 Heterocyclic amides and/or isosteres used as antiinflammatory agents or for prophylaxis of nervous system disorders; combinatorial chemistry; substance P antagonists |
| 03/07/2006 | US7008742 dry milling titanyl phthalocyanines and derivatives to form dry amorphous organic pigment mixtures, then heating to form crystal structures used in electrography |
| 03/07/2006 | US7008616 Ephedrine or fenfluramine; aluminum foil coated with a thin layer of drug is heated to form vapor; which condenses to form aerosol; rapid peak plasma concentration |
| 03/07/2006 | US7008615 Delivery of anti-migraine compounds through an inhalation route |
| 03/02/2006 | WO2006023659A2 Novel polymorphs of azabicyclohexane |
| 03/02/2006 | WO2006023381A1 Pyrimidinone compounds |
| 03/02/2006 | WO2006022773A1 Gyrase inhibitors and uses thereof |
| 03/02/2006 | WO2006021213A2 Vasopressin v1a antagonists |
| 03/02/2006 | WO2005121145A3 Octahydro-pyrrolo[3,4-c] derivatives and their use as antiviral compounds |
| 03/02/2006 | WO2005077951A3 7h-pyrrolopyrimidine derivatives |
| 03/02/2006 | WO2005009387A3 Azepine derivatives as pharmaceutical agents |
| 03/02/2006 | WO2004103958A3 Preparation of hymenialdisine derivatives and use thereof |
| 03/02/2006 | WO2003082208A3 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders |
| 03/02/2006 | US20060047128 (R)-O,O'-(9,9'-Spirobixanthene-1,1'-diyl)-N,N-Dimethylphosphoramide [(R)-4] ligand forms hydrogenation catalyst with Rh compounds for asymmetrical hydrogenation of olefins, imines, enamides and ketones |
| 03/02/2006 | US20060047118 New pteridinones as PLK inhibitors |
| 03/02/2006 | US20060047117 Direct esterification of corresponding acids to form prodrugs for cancer treatment on skins using alcohol |
| 03/02/2006 | US20060047112 Easily deformed in accordance with exerted force when the force is externally exerted and is high in its electric conductivity; used as a material of a flexible electronic device. |
| 03/02/2006 | US20060047111 Easily deformed in accordance with exerted force when the force is externally exerted and is high in its electric conductivity; used as a material of a flexible electronic device |
| 03/02/2006 | US20060046995 anti-bacterial agents; staphylococci; coliform bacteria; 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; bridged bicyclic ureas or carbamates having bridgehead nitrogen |
| 03/02/2006 | US20060046992 Heterobicyclic compounds |
| 03/02/2006 | US20060046985 Tetrahydro--4h-pyrido[1,2-a}pyrimidines and related compounds useful as hiv integrase inhibitors |
| 03/02/2006 | US20060046983 Inhibitors of HCV replication |
| 03/02/2006 | DE102004039789A1 Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Aryl-substituted polycyclic amines, process for their preparation and their use as medicaments |
| 03/02/2006 | CA2689274A1 Vasopressin via antagonists |
| 03/02/2006 | CA2688912A1 Vasopressin v1a antagonists |
| 03/02/2006 | CA2688865A1 Vasopressin v1a antagonists |
| 03/02/2006 | CA2578409A1 A method for preparing irbesartan and intermediates thereof |
| 03/02/2006 | CA2578370A1 Triazolobenzodiazepines and their use as vasopressin antagonists |
| 03/02/2006 | CA2578075A1 Aminoheteroaryl compounds as protein tyrosine kinase inhibitors |
| 03/02/2006 | CA2576465A1 Fused triazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 03/01/2006 | EP1630165A1 [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 03/01/2006 | EP1630164A1 Pyrazolopyrimidinones as phosphodiesterase inhibitors |
| 03/01/2006 | EP1630162A1 2-aminoquinoline derivative |
| 03/01/2006 | EP1628981A2 Bicyclicpyrimidones and their use to treat diseases |
| 03/01/2006 | EP1628980A1 6-arylmethyl-substituted pyrazolopyrimidines |
| 03/01/2006 | EP1628979A1 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors |
| 03/01/2006 | EP1628976A1 Novel pyridopyrazines and use thereof as kinase inhibitors |
| 03/01/2006 | EP1628973A2 Processes for preparation of ziprasidone |
| 03/01/2006 | EP1628958A2 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |
| 03/01/2006 | EP1532146B1 A method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives |
| 03/01/2006 | EP1472255B1 Aza-arylpiperazines |
| 03/01/2006 | EP1451155A4 Compositions, methods and kits pertaining to luminescent compounds |
| 03/01/2006 | EP1392292B1 Pyranoindazoles and their use for the treatment of glaucoma |
| 03/01/2006 | EP1363910B1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 03/01/2006 | EP1345942B1 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists |
| 03/01/2006 | EP1319661B1 Process for producing a tricyclic fused heterocyclic derivative |
| 03/01/2006 | EP1319007B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/01/2006 | EP1183033B1 Pyrrolotriazine inhibitors of kinases |
| 03/01/2006 | EP1086105B1 Fused azepinone cyclin dependent kinase inhibitors |
| 03/01/2006 | EP1037616B1 COMBINATION OF ALPHA-1-ADRENERGIC ANTAGONISTS AND A CGMP PDEv INHIBITOR FOR THE TREATMENT OF IMPOTENCE |
| 03/01/2006 | CN1742014A Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/01/2006 | CN1742013A Pyrazolopyrimidine compound and method for producing the same |
| 03/01/2006 | CN1742012A Triazolopyridazines as inhibitors of protein kinases |
| 03/01/2006 | CN1740173A Inhibitors of interleukin-1beta converting enzyme |
| 03/01/2006 | CN1243753C Substituted 3,4-dihydro-pyrimido[1,2-A] pyrimidines and 3,4-dihydropyrazino [1,2-A] pyrimidines |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 02/28/2006 | USRE38994 Pyropheophorbides conjugates and their use in photodynamic therapy |
| 02/28/2006 | US7007251 Database mining system and method for coverage analysis of functional verification of integrated circuit designs |
| 02/28/2006 | US7005520 cyclization of a 3-amidyl-4-amino-pyrazole compound with n-hydroxy-5-[(4-methylpiperazin-1-yl)sulfonyl]benzenecarboximidamidine compound; anti-impotency drugs |
| 02/28/2006 | US7005518 use as reporter group for labeling biomolecules; silicon phthalocyanine dyes are water soluble, isomericly pure, possess high quantum yield, and are useful in bioassays; e.g. core atom is a trisiloxane containing ammonium and sulfonic acid groups |
| 02/28/2006 | US7005517 Paramagnetic metal-phthalocyanine complex compounds and contrast agent using the same |
| 02/28/2006 | US7005431 Imidazo-triazine derivatives as ligands for gaba receptors |
| 02/28/2006 | US7005430 Such as (R)-2-cyclopentyl-7,8-dihydro-8-(4-picolyl)-4-(n-propyl)-1H-imidazo(2,1 -i)purin-5(4H)-one d-tartaric acid, which has glucose concentration-dependent insulin secretion promoting action/hypoglycemic activity; antidiabetic agents |
| 02/28/2006 | US7005122 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route |
| 02/28/2006 | US7005121 Arerosol; heating drug, vaporization, cooling |
| 02/28/2006 | CA2173116C Ring-expanded nucleosides and nucleotides |
| 02/23/2006 | WO2006020082A1 Inhibitors of hcv replication |
| 02/23/2006 | WO2006019957A2 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 02/23/2006 | WO2006019955A2 Antiviral methods and compositions |
| 02/23/2006 | WO2006019668A2 (1s,5s)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate |
| 02/23/2006 | WO2006019660A2 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane |
| 02/23/2006 | WO2006018609A2 Anti-inflammatory agents |
| 02/23/2006 | WO2006018475A1 Photovoltaic cell based on vectorial electron transfer |
| 02/23/2006 | WO2006018443A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/23/2006 | WO2006018280A2 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 02/23/2006 | WO2006018279A2 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 02/23/2006 | WO2006001511A8 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
| 02/23/2006 | WO2005115145A3 Quinone substituted quinazoline and quinoline kinase inhibitors |
| 02/23/2006 | WO2005089118A3 Novel bicyclic compounds as modulators of androgen receptor function and method |
| 02/23/2006 | WO2005048953A3 Amide derivatives as kinase modulators |
| 02/23/2006 | US20060041132 Novel triazolo pyrimidine compounds |
| 02/23/2006 | US20060041131 useful in the treatment and prevention of proliferative diseases, for example, cancer, inflammation and arthritis |
| 02/23/2006 | US20060041125 Substituted pyrido-pyridazine derivatives which enhance cognition via the gaba-a receptors |
| 02/23/2006 | US20060041124 Process for preparing pyrrolotriazine kinase inhibitors |
| 02/23/2006 | US20060041121 Method for conversion of terminal alkenes to aldehydes using ruthenium(IV) porphyrin catalysts |
| 02/23/2006 | US20060041120 Tetraazaporphyrin compounds |
| 02/23/2006 | US20060040983 Quinolinyl-pyrrolopyrazoles |
| 02/23/2006 | US20060040971 Dissolving amorphous rapamycin in t-butyl methyl ether and recrystallizing rapamycin to form rapamycin form II; differential scanning calorimetry thermogram lacking an endotherm peak of about 194 degrees; lower melting point than rapamycin, more readily compressible |
| 02/23/2006 | US20060040965 (5,6-Diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(2-morpholin-4-ylethyl)-amine; activated p21cdc42Hs-associated kinase (ACK1) and leukocyte specific protein tyrosine kinase (LCK) inhibitor; antiproliferative and antiinflammatory agent; cancer, osteoporosis |
| 02/23/2006 | US20060040964 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders |
| 02/23/2006 | US20060040963 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/23/2006 | US20060040959 Adenosine A3 receptor modulators |